Citius Pharmaceuticals, Inc. Other Nonoperating Expense
Citius Pharmaceuticals, Inc. (CTXR) reported Other Nonoperating Expense of $48.00 thousand for the 12-month period ending 2016-09-30, per its 10-K filed 2016-12-23.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2016-12-23
- Citius Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2016-09-30 was $12.00K, a 0.00% change year-over-year.
- Citius Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2016-06-30 was $12.00K, a 0.00% change year-over-year.
- Citius Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2016-03-31 was $12.00K, a 0.00% change year-over-year.
- Citius Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2015-12-31 was $12.00K, a 0.00% change year-over-year.
- Citius Pharmaceuticals, Inc. other nonoperating expense for fiscal 2016 was $48.00K, a 0.00% change from fiscal 2015.
- Citius Pharmaceuticals, Inc. other nonoperating expense for fiscal 2015 was $48.00K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 3 month as first filed | Other Nonoperating Expense 6 month | Other Nonoperating Expense 6 month as first filed | Other Nonoperating Expense 9 month | Other Nonoperating Expense 9 month as first filed | Other Nonoperating Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2016-09-30 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | $24.00K derived: sum of 2 quarters · filed 2016-12-23 | $36.00K derived: sum of 3 quarters · filed 2016-12-23 | $48.00K 10-K · filed 2016-12-23 | |||
| 2016-06-30 | $12.00K 10-Q · filed 2016-08-15 | $24.00K derived: sum of 2 quarters · filed 2016-08-15 | $36.00K 10-Q · filed 2016-08-15 | $48.00K derived: sum of 4 quarters · filed 2016-12-23 | |||
| 2016-03-31 | $12.00K 10-Q · filed 2016-05-20 | $24.00K 10-Q · filed 2016-05-20 | $36.00K derived: sum of 3 quarters · filed 2016-12-23 | $48.00K derived: sum of 4 quarters · filed 2016-12-23 | |||
| 2015-12-31 | $12.00K 10-Q · filed 2016-02-12 | $24.00K derived: sum of 2 quarters · filed 2016-12-23 | $36.00K derived: sum of 3 quarters · filed 2016-12-23 | $48.00K derived: sum of 4 quarters · filed 2016-12-23 | |||
| 2015-09-30 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | $24.00K derived: sum of 2 quarters · filed 2016-12-23 | $36.00K derived: sum of 3 quarters · filed 2016-12-23 | $48.00K 10-K · filed 2016-12-23 | |||
| 2015-06-30 | $12.00K 10-Q · filed 2016-08-15 | $87.00K 10-Q · filed 2015-08-13 | $24.00K derived: sum of 2 quarters · filed 2016-08-15 | $36.00K 10-Q · filed 2016-08-15 | $261.00K 10-Q · filed 2015-08-13 | ||
| 2015-03-31 | $12.00K 10-Q · filed 2016-05-20 | $87.00K 10-Q · filed 2015-05-13 | $24.00K 10-Q · filed 2016-05-20 | $174.00K 10-Q · filed 2015-05-13 | |||
| 2014-12-31 | $12.00K 10-Q · filed 2016-02-12 | $87.00K 10-Q · filed 2015-02-17 | |||||
| 2014-09-30 | $4.00K 10-K · filed 2016-12-23 | $29.00K 10-KT · filed 2014-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |